Emerging research suggest Retatrutide , a dual agonist targeting both the gut-brain axis and glucose-dependent insulinotropic polypeptide , may represent a significant step forward for obesity loss . Early https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026